| # | Title | Journal | Year | Citations |
|---|
| 1 | IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy | Nature Genetics | 2009 | 1,808 |
| 2 | Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate | Gastrointestinal Endoscopy | 2006 | 402 |
| 3 | Host genetic factors influence disease progression in chronic hepatitis C | Hepatology | 2000 | 369 |
| 4 | Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis | Gastroenterology | 2002 | 265 |
| 5 | Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C | Gut | 2002 | 259 |
| 6 | Prevalence of Eosinophilic Esophagitis in Adults With Food Bolus Obstruction of the Esophagus | Journal of Clinical Gastroenterology | 2007 | 188 |
| 7 | Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered | Journal of Hepatology | 2009 | 156 |
| 8 | Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease | Nature Communications | 2015 | 156 |
| 9 | Review of genetic and epigenetic alterations in hepatocarcinogenesis | Journal of Gastroenterology and Hepatology (Australia) | 2006 | 141 |
| 10 | Dyspepsia and the microbiome: time to focus on the small intestine | Gut | 2017 | 139 |
| 11 | Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3 | Journal of Gastroenterology and Hepatology (Australia) | 2001 | 134 |
| 12 | Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation | Journal of Hepatology | 2001 | 133 |
| 13 | Causes and Consequences of Innate Immune Dysfunction in Cirrhosis | Frontiers in Immunology | 2019 | 116 |
| 14 | Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview | Digestive Diseases | 2017 | 115 |
| 15 | Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions | Gut | 2017 | 113 |
| 16 | Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors | Digestive Diseases and Sciences | 2019 | 102 |
| 17 | Hemochromatosis and alcoholic liver disease | Alcohol | 2003 | 101 |
| 18 | Detection of male DNA in the liver of female patients with primary biliary cirrhosis | Journal of Hepatology | 2000 | 86 |
| 19 | Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease | Journal of Hepatology | 2010 | 85 |
| 20 | Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis | Internal Medicine Journal | 2018 | 80 |
| 21 | Prediction of Clinically Significant Bleeding Following Wide-Field Endoscopic Resection of Large Sessile and Laterally Spreading Colorectal Lesions: A Clinical Risk Score | American Journal of Gastroenterology | 2016 | 78 |
| 22 | Prophylactic Endoscopic Coagulation to Prevent Bleeding After Wide-Field Endoscopic Mucosal Resection of Large Sessile Colon Polyps | Clinical Gastroenterology and Hepatology | 2015 | 74 |
| 23 | Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor‐α and cytochrome P450 2E1 | Journal of Gastroenterology and Hepatology (Australia) | 2003 | 72 |
| 24 | Influence of cigarette smoking on the human duodenal mucosa-associated microbiota | Microbiome | 2018 | 72 |
| 25 | Serum ferritin concentration predicts mortality in patients awaiting liver transplantation | Hepatology | 2010 | 70 |
| 26 | The size, morphology, site, and access score predicts critical outcomes of endoscopic mucosal resection in the colon | Endoscopy | 2018 | 70 |
| 27 | Can paracetamol (acetaminophen) be administered to patients with liver impairment? | British Journal of Clinical Pharmacology | 2016 | 69 |
| 28 | Characterisation of the gastrointestinal mucosa‐associated microbiota: a novel technique to prevent cross‐contamination during endoscopic procedures | Alimentary Pharmacology and Therapeutics | 2016 | 69 |
| 29 | Nonalcoholic fatty liver disease burden: Australia, 2019–2030 | Journal of Gastroenterology and Hepatology (Australia) | 2020 | 68 |
| 30 | FibroGENE: A gene-based model for staging liver fibrosis | Journal of Hepatology | 2016 | 64 |
| 31 | Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort | Genome Medicine | 2011 | 62 |
| 32 | ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity | Liver International | 2015 | 60 |
| 33 | Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography | Inflammatory Bowel Diseases | 2019 | 60 |
| 34 | The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis | Liver International | 2012 | 55 |
| 35 | Awareness and opinions of non‐alcoholic fatty liver disease by hospital specialists | Internal Medicine Journal | 2013 | 55 |
| 36 | Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease | Seminars in Liver Disease | 2017 | 55 |
| 37 | A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care | Hepatology Communications | 2018 | 54 |
| 38 | Duodenal expression of iron transport molecules in untreated haemochromatosis subjects | Gut | 2003 | 53 |
| 39 | CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites | JCI Insight | 2016 | 53 |
| 40 | Screening for hemochromatosis | Clinica Chimica Acta | 2002 | 52 |
| 41 | The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease | Liver International | 2016 | 51 |
| 42 | Low-titre auto-antibodies predict autoimmune disease during interferon-α treatment of chronic hepatitis C | Journal of Gastroenterology and Hepatology (Australia) | 2002 | 47 |
| 43 | Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? | Internal Medicine Journal | 2014 | 47 |
| 44 | Increased hepatic iron and cirrhosis: No evidence for an adverse effect on patient outcome following liver transplantation | Hepatology | 2000 | 46 |
| 45 | Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis | Journal of Hepatology | 2008 | 46 |
| 46 | Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis | Hepatology | 2009 | 46 |
| 47 | Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease | Proceedings of the National Academy of Sciences of the United States of America | 2022 | 44 |
| 48 | Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases | Digestive Diseases | 2010 | 43 |
| 49 | Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection | Hepatology | 2000 | 42 |
| 50 | Portal, but not lobular, macrophages express matrix metalloproteinase‐9: association with the ductular reaction and fibrosis in chronic hepatitis C | Liver International | 2013 | 42 |
